Cargando…
Suppression of the NF-κB co-factor, Bcl3, delays the metastatic progression of breast cancer
Autores principales: | Wakefield, AM, Clarkson, RWE |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875568/ http://dx.doi.org/10.1186/bcr2503 |
Ejemplares similares
-
Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis
por: Wakefield, A, et al.
Publicado: (2008) -
TNF-alpha induced chondrocyte apoptosis in NF-κB suppression is augmented by inhibition of p38 mitogen-activated protein kinase or phosphatidylinositol 3-kinase
por: Kim, H
Publicado: (2003) -
Progress towards unlocking the secrets of oestrogen receptor beta in breast cancer
por: Speirs, V, et al.
Publicado: (2006) -
Inhibitory effects of evodiamine on zymosan-induced inflammation: inactivation of NF-κB by inhibiting IκBα phosphorylation
por: Fan, X, et al.
Publicado: (2014) -
Insulin exerts anti-inflammatory effects through reduction of IKK/IκB/NF-κB pathway activation in septic rats
por: Mittestainer, F, et al.
Publicado: (2012)